期刊文献+

Hepatogenous diabetes: Is it a neglected condition in chronic liver disease? 被引量:15

Hepatogenous diabetes: Is it a neglected condition in chronic liver disease?
下载PDF
导出
摘要 Diabetes mellitus(DM) that occurs because of chronic liver disease(CLD) is known as hepatogenous diabetes(HD). Although the association of diabetes and liver cirrhosis was described forty years ago, it was scarcely studied for long time. Patients suffering from this condition have low frequency of risk factors of type 2 DM. Its incidence is higher in CLD of viral, alcoholic and cryptogenic etiology. Its pathophysiology relates to liver damage, pancreatic dysfunction, interactions between hepatitis C virus(HCV) and glucose metabolism mechanisms and genetic susceptibility. It associates with increased rate of liver complications and hepatocellular carcinoma, and decreased 5-year survival rate. It reduces sustained virological response in HCV infected patients. In spite of these evidences, the American Diabetes Association does not recognize HD. In addition, the impact of glucose control on clinical outcomes of patients has not been evaluated. Treatment of diabetes may be difficult due to liver insufficiency and hepatotoxicity of antidiabetic drugs. Notwithstanding, no therapeutic guidelines have been implemented up to date. In this editorial, authors discuss the reasons why they think that HD may be a neglected pathological condition and call attention to the necessity for more clinical research on different fields of this disease. Diabetes mellitus (DM) that occurs because of chronic liver disease (CLD) is known as hepatogenous diabetes (HD). Although the association of diabetes and liver cirrhosis was described forty years ago, it was scarcely studied for long time. Patients suffering from this condition have low frequency of risk factors of type 2 DM. Its incidence is higher in CLD of viral, alcoholic and cryptogenic etiology. Its pathophysiology relates to liver damage, pancreatic dysfunction, interactions between hepatitis C virus (HCV) and glucose metabolism mechanisms and genetic susceptibility. It associates with increased rate of liver complications and hepatocellular carcinoma, and decreased 5-year survival rate. It reduces sustained virological response in HCV infected patients. In spite of these evidences, the American Diabetes Association does not recognize HD. In addition, the impact of glucose control on clinical outcomes of patients has not been evaluated. Treatment of diabetes may be difficult due to liver insufficiency and hepatotoxicity of antidiabetic drugs. Notwithstanding, no therapeutic guidelines have been implemented up to date. In this editorial, authors discuss the reasons why they think that HD may be a neglected pathological condition and call attention to the necessity for more clinical research on different fields of this disease.
出处 《World Journal of Gastroenterology》 SCIE CAS 2016年第10期2869-2874,共6页 世界胃肠病学杂志(英文版)
基金 Supported by the Department of Endocrinology and Service of Gastroenterology of the Faculty of Medicine Autonomous University of Nuevo Leon
关键词 Hepatogenous DIABETES DIABETES MELLITUS OUTCOMES Therapy HEPATITIS C virus CHRONIC liver disease Hepatogenous diabetes Diabetes mellitus Outcomes Therapy Hepatitis C virus Chronic liver disease
  • 相关文献

参考文献54

  • 1Anonymous.??Diagnosis and Classification of Diabetes Mellitus(J)Diabetes Care . 2012
  • 2Gisèle Nkontchou,Emmanuel Cosson,Mounir Aout,Amel Mahmoudi,Valérie Bourcier,Iliass Charif,Nathalie Ganne-Carrie,Véronique Grando-Lemaire,Eric Vicaut,Jean-Claude Trinchet,Michel Beaugrand.Impact of Metformin on the Prognosis of Cirrhosis Induced by Viral Hepatitis C in Diabetic Patients[J].The Journal of Clinical Endocrinology & Metabolism.2011(8)
  • 3Preeti R. John,Paul J. Thuluvath.??Outcome of liver transplantation in patients with diabetes mellitus: A case-control study(J)Hepatology . 2001 (5)
  • 4Luc Tappy,Kaori Minehira.??New data and new concepts on the role of the liver in glucose homeostasis(J)Current Opinion in Clinical Nutrition and Metabolic Care . 2001 (4)
  • 5Kenichi Ikejima,Hajime Honda,Mutsuko Yoshikawa,Miyoko Hirose,Tsuneo Kitamura,Yoshiyuki Takei,Nobuhiro Sato.??Leptin augments inflammatory and profibrogenic responses in the murine liver induced by hepatotoxic chemicals(J)Hepatology . 2001 (2)
  • 6Guobin He,Guann-Yi Yu,Vladislav Temkin,Hisanobu Ogata,Christian Kuntzen,Toshiharu Sakurai,Wolfgang Sieghart,Markus Peck-Radosavljevic,Hyam L. Leffert,Michael Karin.Hepatocyte IKKβ/NF-κB Inhibits Tumor Promotion and Progression by Preventing Oxidative Stress-Driven STAT3 Activation[J].Cancer Cell.2010(3)
  • 7Rami Moucari,Tarik Asselah,Dominique Cazals–Hatem,Hélène Voitot,Nathalie Boyer,Marie–Pierre Ripault,Rodolphe Sobesky,Michèle Martinot–Peignoux,Sarah Maylin,Marie–Hélène Nicolas–Chanoine,Valérie Paradis,Michel Vidaud,Dominique Valla,Pierre Bedossa,Patrick Marcellin.??<ce:link locator='fx1'/> <ce:link locator='fx2'/> Insulin Resistance in Chronic Hepatitis C: Association With Genotypes 1 and 4, Serum HCV RNA Level, and Liver Fibrosis(J)Gastroenterology . 2008 (2)
  • 8Rodolphe Anty,Eve Gelsi,Jean Giudicelli,Eugenia Mariné-Barjoan,Philippe Gual,Sylvia Benzaken,Marie-Christine Saint-Paul,Jean Louis Sadoul,Pierre Michel Huet,Albert Tran.??Glucose intolerance and hypoadiponectinemia are already present in lean patients with chronic hepatitis C infected with genotype non-3 viruses(J)European Journal of Gastroenterology & Hepatology . 2007 (8)
  • 9Shuji Sumie,Takumi Kawaguchi,Mina Komuta,Ryoko Kuromatsu,Satoshi Itano,Koji Okuda,Eitaro Taniguchi,Eiji Ando,Akio Takata,Nobuyoshi Fukushima,Hironori Koga,Takuji Torimura,Masamichi Kojiro,Michio Sata.??Significance of glucose intolerance and SHIP2 expression in hepatocellularcarcinoma patients with HCV infection(J)Oncology Reports . 2007 (3)
  • 10S. Y.Kwon,S. S.Kim,O. S.Kwon,K. A.Kwon,M. G.Chung,D. K.Park,Y. S.Kim,Y. S.Koo,Y. K.Kim,D. J.Choi,J. H.Kim.??Prognostic significance of glycaemic control in patients with HBV and HCV‐related cirrhosis and diabetes mellitus(J)Diabetic Medicine . 2005 (11)

二级参考文献214

共引文献176

同被引文献148

引证文献15

二级引证文献76

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部